52

  

  

McPHERSON’S LIMITED

 ANNUAL REPORT 2015

NOTE 2.  FINANCIAL RISK MANAGEMENT (CONTINUED)

(D) LIQUIDITY RISK (CONTINUED)

Maturity profile of the Group’s borrowings

The table below analyses the Group’s financial liabilities into relevant maturity groupings based on the remaining period at balance date to the 

contractual maturity date.  The amounts disclosed are the contractual undiscounted cash flows.

LESS THAN

1 YEAR

$’000

BETWEEN

1 & 2 YEARS

$’000

BETWEEN

2 & 3 YEARS

$’000

BETWEEN

4 & 6 YEARS

$’000

TOTAL

CONTRACTUAL

CASH FLOWS

$’000

CARRYING

AMOUNT

$’000

30 June 2015

Non-derivatives
Payables

60,427

-

-

-

60,427

60,427

Contingent consideration

1

6,637

-

-

-

6,637

6,637

Borrowings

5,527

34,850

37,646

33,728

111,751

88,475

Total non-derivative financial liabilities

72,591

34,850

37,646

33,728

178,815

155,539

Derivatives
Interest rate contracts

409

410

410

781

2,010

2,010

Foreign currency options

802

-

-

-

802

802

Total derivative financial instrument 

liabilities

1,211

410

410

781

2,812

2,812

30 June 2014

Non-derivatives
Payables

50,627

-

-

-

50,627

50,627

Contingent consideration

1

4,170

8,715

-

-

12,885

12,885

Borrowings

7,115

78,024

-

-

85,139

78,820

Total non-derivative financial liabilities

61,912

86,739

-

-

148,651

142,332

Derivatives 
Forward foreign exchange contracts - inflow

(46,945)

-

-

-

(46,945)

-

Forward foreign exchange contracts - outflow

49,074

-

-

-

49,074

1,952

2,129

-

-

-

2,129

1,952

Interest rate contracts

835

835

142

-

1,812

1,812

Foreign currency options

1,184

-

-

-

1,184

1,068

Total derivative financial instrument 

liabilities

4,148

835

142

-

5,125

4,832

1. The amounts disclosed above in relation to contingent consideration are based on management’s best estimates of the likely future payments based on the facts and circumstances in existence 

at 30 June 2015 and 30 June 2014 respectively.  The final payment amounts may significantly differ from the amounts disclosed above.  Refer to Note 31 for further information.

NOTES TO AND FORMING PART OF THE  

CONSOLIDATED FINANCIAL STATEMENTS CONTINUED